Vasilakou D, Karagiannis T, Athanasiadou E, et al
Although extremely rare - occurring in about 0.03 cases per 1,000 patient-years - MALA can be fatal in 30% to 50% of cases when it does occur
Structural improvements increased albumin affinity, allowing for once-weekly dosing [29,30]
Key areas to watch include the rise in mass tort litigation and potential class action lawsuits related to Ozempic
An individual who is pregnant or breast-feeding, has active cancer, or untreated hormone sensitive conditions should not undergo peptide therapy
HRS Congress 2026 Dr Kenneth Bilchick (UVA Heart & Vascular Center, Charlottesville, VA, US) joins us to discuss findings from a study examining whether the protective effect of glucagon-like peptide-1 (GLP-1) receptor agonists on atrial fibrillation risk operates independently of weight loss and survival